Beyond Meds highlights a reappraisal of Andrew Solomon, whose book “The Noonday Demon: An Atlas of Depression” is often pointed to as testimony for the effectiveness of psychiatric treatment. Solomon’s trajectory, the article claims, could be understood to be a tragedy of iatrogenic problems and withdrawal, culminating in Solomon’s father – a pharma executive who tauted psychopharmaceuticals in part as a result of his belief that his son had benefitted from them – being targeted by the U.S. Office of the Inspector General for overly aggressive marketing of antidepressants.
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.